<DOC>
	<DOCNO>NCT02180516</DOCNO>
	<brief_summary>Study assess safety profile meloxicam compare incidence gastrointestinal adverse event meloxicam NSAID routine daily therapeutic situation .</brief_summary>
	<brief_title>Safety Efficacy Meloxicam Compared Other Nonsteroidal Antiinflammatory Drugs ( NSAIDs ) Observational Cohort Study Patients With Rheumatoid Arthritis , Osteoarthritis , Lumbago , Scapulohumeral Periarthritis , Neck , Shoulder Arm Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Periarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Etodolac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patients Indications accord package insert prescribe NSAID There exclusion criterion , Post Marketing Study observational study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>